1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

NovoCodex Biopharmaceuticals Co., Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

Shaoxing Zhejiang China

Primary Industry

Pharmaceuticals

About

Established in 2017 and based in Shaoxing, China, NovoCodex Biopharmaceuticals Co., Ltd. is a subsidiary of a listed pharmaceuticals company Zhejiang Medicine Co., Ltd., provides innovation drugs for cancer. The company has 96 employees, including 13 doctors and 24 masters. The company was selected as a science and technology-based small and medium-sized enterprise in Zhejiang Province in 2020, and received the Shaoxing City 2020 High Quality Contribution Award and other honors. The firm currently provides innovative biological drug anti-HER2, which is the first to use unnatural amino acids to insert proteins into the protein to achieve precise coupling of toxins on the monoclonal antibody molecules for the treatment of HER2 Positive recurrent breast cancer and gastric cancer. At present, the breast cancer registration clinical research of ARX788 is in the enrollment stage, and the gastric cancer registration clinical research is actively preparing. ARX305 is currently in the pre-clinical evaluation and research stage, and it is expected to submit an IND registration application in 2022. In addition, the technology platform that the company have many products under development.
Current Investors
Lilly Asia Ventures, MPC, Sanhhua Hongdao Capital

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.novocodex.cn
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.